[
  {
    "ts": "2025-12-02T13:00:00+00:00",
    "headline": "Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.",
    "summary": "Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion’s commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a heal",
    "url": "https://finance.yahoo.com/news/aclarion-appoints-jason-brosniak-commercial-130000870.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e9922eae-7623-3020-9f20-feed1540f131",
      "content": {
        "id": "e9922eae-7623-3020-9f20-feed1540f131",
        "contentType": "STORY",
        "title": "Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.",
        "description": "",
        "summary": "Proven commercial leader with 20+ years of experience driving revenue growth and market adoption for early-stage and high-growth MedTech companiesStrong track record of launching breakthrough technologies across spine, neurosurgery and pain managementStrengthens Aclarion’s commercial execution as the Company expands adoption and payer engagement across the Eastern U.S. BROOMFIELD, Colo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a heal",
        "pubDate": "2025-12-02T13:00:00Z",
        "displayTime": "2025-12-02T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e94b9774078b1f9918b0fd65108ae0e2",
          "originalWidth": 140,
          "originalHeight": 83,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fXqw9uDnm_uTzhrSWrDMoA--~B/aD04Mzt3PTE0MDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/e94b9774078b1f9918b0fd65108ae0e2.cf.webp",
              "width": 140,
              "height": 83,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NeLVsJaPiFlcqjtV4J4hjQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e94b9774078b1f9918b0fd65108ae0e2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/aclarion-appoints-jason-brosniak-commercial-130000870.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/aclarion-appoints-jason-brosniak-commercial-130000870.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ACON"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T12:56:00+00:00",
    "headline": "M&A Strategy Strengthens Boston Scientific's Growth Prospects",
    "summary": "BSX accelerates growth as a wave of acquisitions boosts core portfolios and fuels expansion into high-growth adjacent markets.",
    "url": "https://finance.yahoo.com/news/m-strategy-strengthens-boston-scientifics-125600241.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "16385954-e8bd-3cb9-8a98-cb98b81ec9ad",
      "content": {
        "id": "16385954-e8bd-3cb9-8a98-cb98b81ec9ad",
        "contentType": "STORY",
        "title": "M&A Strategy Strengthens Boston Scientific's Growth Prospects",
        "description": "",
        "summary": "BSX accelerates growth as a wave of acquisitions boosts core portfolios and fuels expansion into high-growth adjacent markets.",
        "pubDate": "2025-12-02T12:56:00Z",
        "displayTime": "2025-12-02T12:56:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/m-strategy-strengthens-boston-scientifics-125600241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/m-strategy-strengthens-boston-scientifics-125600241.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "TFX"
            },
            {
              "symbol": "ELUT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T12:53:00+00:00",
    "headline": "Should You Continue to Hold LH Stock in Your Portfolio?",
    "summary": "Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.",
    "url": "https://finance.yahoo.com/news/continue-hold-lh-stock-portfolio-125300895.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "72921acd-30fa-36b9-9ec9-3c1a3529f8ce",
      "content": {
        "id": "72921acd-30fa-36b9-9ec9-3c1a3529f8ce",
        "contentType": "STORY",
        "title": "Should You Continue to Hold LH Stock in Your Portfolio?",
        "description": "",
        "summary": "Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.",
        "pubDate": "2025-12-02T12:53:00Z",
        "displayTime": "2025-12-02T12:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/continue-hold-lh-stock-portfolio-125300895.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/continue-hold-lh-stock-portfolio-125300895.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LH"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "GMED"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T13:26:00+00:00",
    "headline": "Baxter Issues Recall Notice for Permanent Removal of Life2000 Ventilation",
    "summary": "Baxter recalls its Life2000 ventilation system over a serious cybersecurity flaw, pulling the device from the market despite no reported injuries.",
    "url": "https://finance.yahoo.com/news/baxter-issues-recall-notice-permanent-132600603.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "fafb45e6-0ec5-34ef-b151-a4b5d7140bdc",
      "content": {
        "id": "fafb45e6-0ec5-34ef-b151-a4b5d7140bdc",
        "contentType": "STORY",
        "title": "Baxter Issues Recall Notice for Permanent Removal of Life2000 Ventilation",
        "description": "",
        "summary": "Baxter recalls its Life2000 ventilation system over a serious cybersecurity flaw, pulling the device from the market despite no reported injuries.",
        "pubDate": "2025-12-02T13:26:00Z",
        "displayTime": "2025-12-02T13:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/58ce597148fe2975e797da8cdeac84fb",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hraFoKQNxMRHk6kckBwr9g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/58ce597148fe2975e797da8cdeac84fb.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Lln5wmk2kX62Xs6ofefhmw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/58ce597148fe2975e797da8cdeac84fb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/baxter-issues-recall-notice-permanent-132600603.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/baxter-issues-recall-notice-permanent-132600603.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAX"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T13:25:00+00:00",
    "headline": "HSIC Stock Benefits From Expanded Partnership With vVARDIS",
    "summary": "Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.",
    "url": "https://finance.yahoo.com/news/hsic-stock-benefits-expanded-partnership-132500993.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "375ccf35-15f6-3c50-8d01-8fd76d5b09cd",
      "content": {
        "id": "375ccf35-15f6-3c50-8d01-8fd76d5b09cd",
        "contentType": "STORY",
        "title": "HSIC Stock Benefits From Expanded Partnership With vVARDIS",
        "description": "",
        "summary": "Henry Schein gains exclusive U.S. rights to Curodont, expanding its vVARDIS partnership and boosting expectations for a Dental business rebound.",
        "pubDate": "2025-12-02T13:25:00Z",
        "displayTime": "2025-12-02T13:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hsic-stock-benefits-expanded-partnership-132500993.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hsic-stock-benefits-expanded-partnership-132500993.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HSIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-02T16:08:00+00:00",
    "headline": "How The BioEnvelope Sale Is Changing Elutia’s Story and Shaping Its Future Valuation",
    "summary": "Elutia's stock narrative has shifted following analysts' latest reassessment, following the company's recent strategic divestiture. While the fair value estimate remains steady, a slight increase in the discount rate signals cautious sentiment about risk and return. Stay tuned to discover how you can monitor Elutia's evolving outlook and stay informed about future updates. Stay updated as the Fair Value for Elutia shifts by adding it to your watchlist or portfolio. Alternatively, explore our...",
    "url": "https://finance.yahoo.com/news/bioenvelope-sale-changing-elutia-story-160800105.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b435451f-a1b6-33b7-a49e-580089a4e2f2",
      "content": {
        "id": "b435451f-a1b6-33b7-a49e-580089a4e2f2",
        "contentType": "STORY",
        "title": "How The BioEnvelope Sale Is Changing Elutia’s Story and Shaping Its Future Valuation",
        "description": "",
        "summary": "Elutia's stock narrative has shifted following analysts' latest reassessment, following the company's recent strategic divestiture. While the fair value estimate remains steady, a slight increase in the discount rate signals cautious sentiment about risk and return. Stay tuned to discover how you can monitor Elutia's evolving outlook and stay informed about future updates. Stay updated as the Fair Value for Elutia shifts by adding it to your watchlist or portfolio. Alternatively, explore our...",
        "pubDate": "2025-12-02T16:08:00Z",
        "displayTime": "2025-12-02T16:08:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I2k3PKJsWIEX9xgEQz8JwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tmSjpFKmBAT61w1lG5.BLQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bioenvelope-sale-changing-elutia-story-160800105.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bioenvelope-sale-changing-elutia-story-160800105.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELUT"
            },
            {
              "symbol": "BSX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]